Zacks Investment Ideas feature highlights: Eli Lilly, Eaton and Interactive Brokers

03.09.25 09:55 Uhr

Werte in diesem Artikel
Aktien

645,00 EUR -2,00 EUR -0,31%

Indizes

PKT PKT

17.880,1 PKT -148,9 PKT -0,83%

3.275,9 PKT 7,5 PKT 0,23%

6.584,3 PKT -3,2 PKT -0,05%

For Immediate ReleaseChicago, IL – September 3, 2025 – Today, Zacks Investment Ideas feature highlights Eli Lilly LLY, Eaton ETN and Interactive Brokers IBKR.These 3 Companies Are Seeing Supercharged Sales GrowthThe 2025 Q2 earnings cycle is now behind us, with the majority of S&P 500 companies already delivering results. The period was one of resilience, with overall growth remaining strong alongside positive revisions for the upcoming Q3 cycle.But more specifically, this cycle, several companies – Eli Lilly, Eaton and Interactive Brokers – posted rock-solid results.Let’s take a closer look at what drove the positivity.Eli Lilly Raises GuidanceLLY shares have faced pressure in 2025 so far, down 5% overall and widely underperforming relative to the S&P 500. But shares have shown nice life off the post-earnings lows so far, with insiders also dipping in.LLY posted Q2 sales of $15.5 billion, up 38% YoY and reflecting a 6% surprise relative to the Zacks Consensus sales estimates. Volume growth across Zepbound and Mounjaro helped lead the positive quarter, with sales of each up 172% and 68%, respectively.The favorable results led LLY to increase its FY25 revenue and adjusted EPS guidance, with its gross margin also moving higher to 84.3% vs the 80.8% mark in the year-ago period. Analysts have revised EPS expectations positively following the release, a bullish sign concerning near-term price action.IBKR Sees Strong Platform GrowthIBKR shares have delivered a strong performance over the past year, up nearly 110% and widely outperforming relative to the S&P 500. Favorable quarterly results have aided the move, with shares seeing nice strength following its latest print.The stock sports a favorable Zacks Rank #2 (Buy), with analysts revising their EPS expectations higher across the board over recent months.The company’s results have been aided by higher customer trading volumes, with volumes in stocks, options, and futures increasing 31%, 24% and 18%, respectively, throughout its latest period. Commission revenue of $516 million throughout the period shot 27% higher year-over-year.Perhaps most importantly, customers continue flocking to the platform, with customer accounts growing by a sizable 32% year-over-year to 3.9 million throughout the period. Below is a chart illustrating the company’s sales on a quarterly basis.Eaton Breaks RecordsEaton is an intelligent power management company that provides products for the data center, utility, industrial, commercial, machine building, residential, aerospace, and mobility markets. Shares have been a big beneficiary of the AI frenzy thanks to the data center exposure.Accelerating orders and continued backlog growth contributed to its recent record-breaking quarter, with adjusted EPS of $2.95 reflecting a Q2 record and up 8% year-over-year. Organic sales grew 8% from the year-ago period, with segment margins of 23.9% also reflecting a Q2 record.ETN shares also reflect a great opportunity for those with an appetite for income, sporting a 7.5% five-year annualized dividend growth rate. Impressively, the company has paid a dividend on its shares every year since 1923. Below is a chart illustrating its dividends paid on an annual basis.Please note that the final value is calculated on a trailing twelve-month basis, as ETN’s current fiscal-year is still ongoing.Bottom LineThe 2025 Q2 earnings season is now behind us, with the period largely positive and resilient.And throughout the period, several companies – including those listed above – posted strong quarterly results.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY): Free Stock Analysis Report Eaton Corporation, PLC (ETN): Free Stock Analysis Report Interactive Brokers Group, Inc. (IBKR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Eli Lilly und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Eaton

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Eaton

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Eli Lilly

Wer­bung

Analysen zu Eli Lilly

DatumRatingAnalyst
20.12.2024Eli Lilly BuyJefferies & Company Inc.
31.10.2024Eli Lilly BuyJefferies & Company Inc.
13.02.2024Eli Lilly and BuyJefferies & Company Inc.
05.10.2018Eli Lilly and OutperformBMO Capital Markets
25.07.2018Eli Lilly and NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
20.12.2024Eli Lilly BuyJefferies & Company Inc.
31.10.2024Eli Lilly BuyJefferies & Company Inc.
13.02.2024Eli Lilly and BuyJefferies & Company Inc.
05.10.2018Eli Lilly and OutperformBMO Capital Markets
08.06.2018Eli Lilly and OverweightCantor Fitzgerald
DatumRatingAnalyst
25.07.2018Eli Lilly and NeutralGoldman Sachs Group Inc.
27.04.2017Eli Lilly and HoldArgus Research Company
20.03.2017Eli Lilly and NeutralUBS AG
22.07.2015Eli Lilly and Equal WeightBarclays Capital
08.01.2015Eli Lilly and HoldDeutsche Bank AG
DatumRatingAnalyst
21.04.2017Eli Lilly and UnderperformBMO Capital Markets
15.10.2012Eli Lilly and underperformJefferies & Company Inc.
30.06.2010Eli Lilly ErsteinschätzungSoleil Securities Group, Inc.
14.12.2009Eli Lilly sellGoldman Sachs Group Inc.
02.12.2009Eli Lilly sellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Eli Lilly nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen